Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib
- Status
- TERMINATED
- Phase
- PHASE3
REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy
- Status
- COMPLETED
- Phase
- PHASE3
Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung
- Status
- TERMINATED
- Phase
- N/A
A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase Inhibitors.
- Status
- TERMINATED
- Phase
- PHASE3
Protective Role of Oxcarbazepine in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Canadian Treat and Extend Analysis Trial With Ranibizumab
- Status
- COMPLETED
- Phase
- N/A
LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of LEE011 With Fulvestrant and BYL719 or BKM120 in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS
- Status
- COMPLETED
- Phase
- PHASE4
A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Sonidegib and Lenalidomide After Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant
- Status
- COMPLETED
- Phase
- PHASE4
Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma
- Status
- COMPLETED
- Phase
- PHASE2